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Background: Stem/progenitor cell-based therapy has successfully been used as a novel therapeutic strategy for
vascular diseases triggered by endothelial dysfunction. The aim of this study was to investigate the effects of
mononuclear cell (MNC) therapy in situ on carotid cuff-induced occlusive thrombus in the apolipoprotein E
knockout (apoE-/-) mouse.
Methods: Spleen-derived MNCs were isolated from green fluorescent protein (GFP)-transgenic mice for cell
treatment. A cuff-induced thrombus model was produced by placing a nonconstrictive silastic collar around the left
common carotid artery in 20-week-old female apoE-/- mice. After 10 days, the cuff was removed, and the animals
received in situ MNCs (Cuff-MNC) or vehicle (Cuff-Vehicle) and were compared with sham-operated animals (Sham).
Results: The histological analysis showed that the MNC treatment reverted occlusive thrombus formation
compared to the vehicle and the vessel lumen area to that observed in the Sham group (MNC, 50 ± 4; Vehicle,
20 ± 4; Sham, 55 ± 2 x103 μm2; p< 0.01). The animals that underwent the carotid cuff placement developed
compensatory vessel enlargement, which was reduced by the MNC therapy. In addition, the treatment was able to
reduce superoxide anion production, which likely contributed to the reduced apoptosis that was observed. Lastly,
the immunofluorescence analysis revealed the presence of endothelial progenitor cells (EPCs) in the carotid
endothelia of the apoE-/- mice.
Conclusion: In situ short-term MNC therapy was able to revert cuff-induced occlusive thrombi in the carotid
arteries of apoE-/- mice, possibly through the homing of EPCs, reduction of oxidative stress and decreased
apoptosis.
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Endothelial dysfunction is widely accepted as a funda-
mental pathophysiological mechanism linking various
cardiovascular risk factors, such as atherosclerosis and
thrombosis [1,2]. Despite progress in drug treatments,
researchers have been challenged to develop new suc-
cessful approaches to repair these injuries. In particular,
emphasis has been placed on the experimental and clin-
ical potential of endothelial progenitor cells (EPCs) to* Correspondence: smeyrelles@pq.cnpq.br
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reproduction in any medium, provided the orpromote vascular repair and the reversal of ischemic in-
jury in various tissues [3,4].
The development of ischemic diseases in conditions of
hypercholesterolemia is aggravated by endothelial dys-
function [5,6]. Therefore, the apolipoprotein E-deficient
(apoE-/-) mouse is considered to be the most relevant
model because the animals develop spontaneous hyper-
cholesterolemia and consequently endothelial dysfunc-
tion accompanied by arterial lesions that are similar to
those observed in humans [1,7]. Moreover, recent stud-
ies have demonstrated that the female gender is an im-
portant factor in the development of endothelial
dysfunction and atherosclerosis [1,8,9]. Because the in-
tegrity of the endothelium is important to suppress
thrombosis, the cuff placement model may be and. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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pairment of arterial distensibility.
Recently, we reported that the intravenous administra-
tion of mononuclear cells (MNCs) attenuates the pro-
gression of atherosclerosis in the aortas of apoE-/- mice
by mechanisms that include the homing of EPCs, a de-
crease in oxidative stress and an upregulation of endo-
thelial nitric oxide synthase expression [10]. In the
present study, we tested the hypothesis that in situ




ApoE-/- female mice (20 weeks old) were randomly
divided into three groups: an apoE-/- control group
(Sham, n = 8), apoE-/- treated in situ with MNC group
(Cuff-MNC, n = 8) and apoE-/- treated with DMEM
group (Cuff-Vehicle, n = 8). The animals were obtained
from the animal facilities of the Federal University of
Espirito Santo. The mice were fed a normal chow diet
and water ad libitum and were housed individually in
temperature-controlled rooms (22°C) under a 12 h light/
dark cycle. All of the procedures were conducted in ac-
cordance with the institutional guidelines for animal re-
search, and the protocols were previously approved by
the Institutional Ethics Committee for Use of Animals
(CEUA 007/2008).
Carotid cuff placement
The apoE-/- mice (n = 24) were anesthetized with keta-
mine/xylazine (91.0/9.1 mg/kg, IP). The animals first
underwent splenectomy: (a) the spleen was dissected
through a lateral incision of the abdomen, (b) the vessels
were carefully ligated using a 6.0 silk, and, (c) after the
removal of the spleen, the abdomen was closed layer by
layer with a 6.0 silk. Immediately afterward, the carotid
artery injury was performed based on a previously
described method [11,12]. Cuffs were produced using a
silastic tubing (length, 4 mm; internal diameter, 0.3 mm;
external diameter, 0.5 mm, Clay-Adams, Parasippany,
NJ, USA) and stored at 70% ethanol. As illustrated in
Figure 1, access to the common carotid artery was
through a sagittal anterior neck incision. The common
carotid artery was dissected free from the surrounding
connective tissue, avoiding damage to the vagus nerves
and the carotid bodies. The nonconstrictive cuff was
placed around the left common carotid artery, and the
axial edges of the cuff were approximated by the place-
ment of 3 circumferential silk ties (Cuff groups; n = 16).
In the sham-operated mice (Sham group; n = 8), the neck
wound was closed in one layer with interrupted 6.0 silk
sutures. The entry wound was closed, and the animals
were returned to their cages for recovery from theanesthesia. An inside diameter of 0.3 mm was constrict-
ive and resulted in stenosis of the common carotid
artery.
MNC isolation and treatment
Green fluorescent protein (GFP)-transgenic mice
were euthanized with a sodium thiopental overdose
(100 mg/kg, i.p.). The spleens were explanted and mech-
anically minced, and the tissue homogenates were placed
in 1 mL of Dulbecco’s Modified Eagle Medium (DMEM,
Sigma-Aldrich, St. Louis, MO, USA) at 4°C; the MNCs
were isolated by gradient centrifugation using Histopa-
que 1083 solution (Sigma-Aldrich) and resuspended in
DMEM. The MNCs were counted using a Neubauer
chamber for the further in situ treatment.
After 10 days of carotid artery stenosis induction,
under anesthesia, the cuff was removed, and the MNCs
(106 cells, resuspended in 20 μL of DMEM) were topic-
ally applied once in situ where the cuff was positioned in
50% of the animals (MNC group; n = 7). The cuff was
removed in the other 50% of the animals, and they
received vehicle (20 μL DMEM) only (Vehicle group;
n = 8). The apoE-/- animals that were sham-operated did
not receive any treatment and were used as the hyperch-
olesterolemic control (Sham group; n = 8). The donor-
derived cells were identified using GFP expression
(green cells), which has been used as a reporter gene
[13], with a B-2E/C Nikon filter that provided GFP
excitation and emission at 471 and 504 nm, respectively.
Figure 1 shows a schematic illustration of the time-
course of the cuff-induced artery stenosis and cell
therapy.
Atherosclerotic lipid deposition quantification and
morphometry
A week after the treatment with the MNCs, the animals
were euthanized with a sodium thiopental overdose
(100 mg/kg, i.p.) and perfused via the left ventricle with
Krebs-HEPES for 10 min at 100 mm Hg constant pres-
sure. The left common carotid artery was removed and
embedded in OCT compound (Tissue-Tek; Sakura
Finetek USA, Torrance, CA, USA). The samples were
stored at -80°C until further use. Transverse (8 μm)
cryosections (Leica, CM 1850, Leica, Wetzlar, Germany)
were prepared and mounted on parallel series of gelatin-
coated slides and stained with Oil-Red-O (Sigma-
Aldrich) to detect neutral lipids and with hematoxylin-
eosin (HE) for the conventional histopathology analysis
and morphometry.
The images of the mid-section of the carotid artery
were captured with a color video camera (VKC 15 0,
Hitachi, Tokyo, Japan) connected to a microscope
(Olympus AX70, Olympus, Center Valley, PA, USA) and
were analyzed using Image J program (National Institute
Figure 1 Scheme of the study and carotid artery cuff positioning. Panel A shows the time course of the procedures and treatment of the
animals. Panel B presents macroscopic views of an opened neck of an apoE-/- mouse showing, from left to right, a dissected left common carotid
artery, a silastic cuff being placed around the artery and the cuff tied around the artery.
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groups performed the image analysis to prevent any bias
in the interpretation of the results. By using a 20x ob-
jective, the vessel cross-sectional area (VCSA), which was
bordered by the external elastic membrane, the lumen
cross-sectional area (LCSA), and the arterial wall (intima-
media) area (VCSA-LCSA) were calculated. The vascular
remodeling ratio was obtained by dividing each animal’s
VCSA (apoE
-/- Vehicle- and apoE-/- MNC-treated groups)
by the average VCSA of the apoE
-/- Sham group, and each
sample was scored for the absence of remodeling (0.95-
1.05), inward remodeling (< 0.95), or outward remodel-
ing (> 1.05) [14].
Immunofluorescence
Immunofluorescence was performed according to stand-
ard protocols for EPC detection. Cross-sections (8 μm)
were cut on a cryostat and placed on gelatin-coated
slides. The sections were air-dried, and the slides were
fixed for 5 min in acetone at -20°C. The slides were
incubated with primary antibodies for 2 hours at room
temperature conjugated with fluorescein isothiocyanate
(FITC) against the stem cell growth factor receptor
(CD117), 1:150 (BD Pharmingen, San Diego, CA, USA)
and labeled with phycoerythrin (PE) against stem cell
antigen-1 (Sca1), 1:150 (BD Pharmingen).
Typical images were captured with a color video cam-
era (Nikon Digital Sight DS - U2, Nikon Instruments
Inc., Melville, NY, USA) connected to a fluorescence
microscope (Nikon Eclipse Ti-S). The green fluorescence(FITC) was collected through a B-2E/C Nikon filter that
provided FITC excitation and emission at 490 and
525 nm, respectively; the red fluorescence (PE) was col-
lected through a G-2E/C Nikon filter that provided PE
excitation and emission at 545 and 576 nm, respectively.
To ensure that the fluorescence observed was only due to
antibody labeling, autofluorescence background was elimi-
nated using samples before incubation with antibodies as
negative controls, as follows: (a) tissue sections were visua-
lized using appropriate filters for each fluorochrome used
in the protocol (PE and FITC); (b) gain and exposure para-
meters were adjusted to cancel the autofluorescence of each
fluorochrome separately, and (c) the samples were incu-
bated with the fluorochrome-conjugated antibodies (Sca-1-
PE and CD117-FITC) and photographed using the same
gain and exposure values established for the negative
control.
TUNEL assay
Apoptotic cells were detected with TUNEL assay using
the Cell Death Detection Kit (POD, Roche, Mannheim,
Germany) according to the specifications and instruc-
tions recommended by the manufacturer. Briefly, after
washing in PBS, the sections were incubated with 3%
H2O2 in methanol for 10 minutes. For detecting the
apoptotic DNA fragments in the cuff-induced vascular
remodeling cells, 50 μL of the TUNEL reaction mixture
was added and incubated for 1 hour in a light-protected
humidified chamber at room temperature. Typical
images were captured with a color video camera (Nikon)
Figure 2 Effects of cuff-induced stenosis on the lesion area in
the common carotid artery and the effect of MNC therapy in
apoE-/- mice. The top panel shows typical histological micrographs
stained with Oil-Red-O comparing an artery with stenosis that
received vehicle, an artery with stenosis treated with mononuclear
cells (MNCs) and an artery from a Sham apoE-/- mouse. The bar
graphs show the average lesion areas of the three groups (n = 8 per
group) of apoE-/- mice. The values are the means ± SEM. **p< 0.01
vs Sham; #p< 0.05 vs Vehicle (ANOVA). Scale bar = 100 μm.
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B-2E/C Nikon filter that provided FITC excitation at
490 nm; the emission was monitored at 525 nm.
Dihydroethidium fluorescence of carotid arteries
The oxidative fluorescent dye dihydroethidium (DHE)
was used as in previous study [10]. The unfixed frozen
left common carotid arteries were cut into 8-μm-thick
sections and placed on glass slides. The samples were
incubated with DHE (2x10-6 mol/L) in a light-protected
humidified chamber at 37°C for 30 minutes. The tissue
sections were imaged using an inverted fluorescence
microscope (Nikon Ti-S) with a G-2E/C Nikon filter that
provided excitation at 530 nm and emission at 610 nm.
Cholesterol levels
A blood sample (200 μL) was collected from the carotid
artery of each animal, and the plasma total cholesterol
was measured using a commercial colorimetric kit (Bio-
clin, Belo Horizonte, Brazil).
Statistical analyses
The data are presented as the mean ± SEM. The normal-
ity of the variables was evaluated using the Kolmogorov-
Smirnov test. The statistical analysis was performed
using one-way ANOVA, followed by the Tukey post hoc
test for multiple comparisons. The Student’s t test for in-
dependent samples was used when appropriate. The
statistical significance was set at p< 0.05.
Results
The plasma total cholesterol levels of the 22-week-old
animals fed a regular chow diet were similar among the
apoE-/- Sham group and those that underwent the cuff-
induced artery stenosis, followed by the topical adminis-
tration of vehicle or cell therapy with MNC (372 ± 48,
369 ± 33 and 350 ± 33 mg/dL, respectively, p> 0.05). The
body weight did not differ among the three groups of
apoE-/- mice at the end of the experiment.
Figure 2 shows the effect of the MNC therapy on the
cuff-induced carotid lesion area. As observed in the typ-
ical carotid cross-sections, this procedure resulted in a
large lesion area at the site where the cuff was positioned
for 10 days, when compared with the apoE-/- Sham
mouse. The animals treated with the MNCs showed a
marked reduction of occlusive thrombi. As summarized
in Figure 2 (bar graph), the positioning of the silastic cuff
around the common carotid artery for 10 days, its re-
moval and the topical application of vehicle at this site
(Cuff-Vehicle group) resulted in a significant lipid depos-
ition area when compared to the sham-operated animals
(Sham group) (6.11 ± 0.89 vs 1.64 ± 0.24 x103 μm2, p
< 0.01). After 7 days, the MNC therapy (Cuff-MNC
group) caused a significant reduction in the vascular lipiddeposition area (3.71 ± 0.40 x103 μm2, p< 0.01), but the
area was still significantly (p< 0.05) larger than in the
Sham group.
The second outcome we analyzed was the effect of the
common carotid artery positioning of the cuff on the
morphological parameters. The effect of this procedure
is observed in the typical carotid cross-sections shown
in Figure 3 (top panels): in the apoE-/- mouse that
underwent cuff positioning (Cuff-Vehicle), an increased
wall thickness, a highly vascularized thrombus occupying
most of the lumen and an increased cross-sectional area
when compared with the apoE-/- Sham mouse is
observed, whereas the apoE-/- mouse that received the
topical application of MNCs on the injured vessel after
the cuff removal show a marked reduction of these para-
meters. Figure 3 (bottom panels) summarizes the effect
of the cuff positioning and the cell therapy on the indi-
cated parameters. The vascular lumen area was signifi-
cantly reduced in the Cuff-Vehicle group compared to
the Sham group (20 ± 4 vs 55 ± 2 x103 μm2, p< 0.01), a
result that was completely reversed after 7 days of treat-
ment with MNCs (50 ± 4 x103 μm2, p< 0.01). In
addition, the vessel wall area was significantly thickened
in the Cuff-Vehicle group compared with the Sham
group (105 ± 8 vs 29 ± 3 x103 μm2, p< 0.01), and this
was significantly reduced by the MNC therapy (58 ± 4
Figure 3 Effect of mononuclear cell (MNC) therapy on cuff-induced stenosis in the common carotid arteries of apoE-/- mice. Tope panel
microphotographs are typical cross-sections of common carotid arteries of apoE-/- mice that underwent sham-operation (Sham) or cuff-induced
stenosis followed by the treatment with MNCs or vehicle. Scale bar = 100 μm. Bottom bar graphs show the data of the effects of MNC therapy on
the lumen area, wall area and cross-sectional area. The values are means ± SEM. *p< 0.05 and **p< 0.01 compared to Sham group (ANOVA);
#p< 0.05 and ##p< 0.01 compared to Vehicle group (ANOVA) (n = 8 per group).
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was significantly larger in the Cuff-Vehicle group com-
pared with the Sham group (133 ± 9 vs 82 ± 2 x103 μm2,
p< 0.01) and was partially reduced by the MNC therapy
(112 ± 9 x103 μm2, p< 0.05). As a result of the latter par-
ameter, the calculated remodeling index showed the oc-
currence of an outward remodeling in the Cuff-Vehicle
group and a significant reduction of this index by the
MNC therapy (1.61 ± 0.09 vs 1.35 ± 0.06, p< 0.05), with
the Sham group as the reference value.
Third, we investigated the effect of the carotid artery
cuff-induced stenosis and its treatment with cell therapy
on both oxidative stress and apoptosis. As shown in a
typical microphotograph in Figure 4 (top panel), the
dihydroethidium oxidative assay of the carotid artery
cross sections of the apoE-/- mice that were subjected to
cuff-induced stenosis reveal intense ethidium fluores-
cence (indicative of superoxide production) in the un-
treated mouse (Vehicle) but not in the mouse treated
with MNCs. On average, the carotid arteries from the
apoE-/- mice that underwent the cuff-induced stenosis
showed approximately 50% less (p< 0.01) ethidium
fluorescence in the MCN group than in the Vehicle
group (Figure 4, bottom panel). Similarly, the results ofthe TUNEL assay show an intense fluorescence (indica-
tive of apoptosis) in a cuff-induced injury in the carotid
artery of an untreated apoE-/- mouse but not in the ves-
sel of the mouse subjected to the cell therapy (Figure 5).
Another outcome of the cuff-induced stenosis in the
apoE-/- mice was the homing of EPCs to the injured le-
sion (indicative of vessel injury repair). Figure 6 shows a
typical carotid artery cross-section, revealing specific
fluorescence signals in the mice treated with MNC but
not in the animals treated with vehicle. The endogenous
fluorescence of the MNC-derived GFP confirmed the
presence of these cells in the carotid artery of MNC-
treated mice but not in the vehicle-treated mice (Fig-
ure 6, bottom panel). The homing of EPCs was con-
firmed by the detection of immunofluorescence of Sca-
1-PE and CD117-FITC, markers of EPCs, showing in-
tense Sca-1 and CD117 expression (as shown in merged
images) in the carotid endothelium of MNC-treated
apoE-/- mice in comparison with untreated mice.
Discussion
In the present study, we observed that the in situ
short-term MNC therapy reverted cuff-induced occlu-
sive thrombi in the carotid arteries from apoE-/- mice
Figure 4 Superoxide anion production in the lesion area of
common carotid arteries with cuff-induced stenosis and the
beneficial effect of mononuclear cell (MNC) therapy in apoE-/-
mice. The top panel presents representative histological
micrographs stained with dihydroethidium (DHE), showing intense
bright ethidium fluorescence (red) in the Cuff-Vehicle compared to
the Cuff-MNC mouse. The bar graph shows the average DHE
fluorescence (AU: arbitrary units) comparing the Cuff–Vehicle to
Cuff-MNC mice (n = 8 per group). The values are the means ± SEM.
**p< 0.01 compared to Cuff-Vehicle (Student’s t test). Scale bar:
100 μm.
Figure 6 Localization of endothelial progenitor cells (EPC) and
green fluorescent protein (GFP)-derived mononuclear cells
(MNC). The photomicrographs are typical common carotid cross-
sections stained for the markers Sca-1-PE (stem cell antigen 1-
phycoerythrin) and CD117-FITC (stem cell growth factor receptor-
fluorescein isothiocyanate), showing an intense immunofluorescent
reaction in MNC-treated apoE-/- animals (indicated by the arrows
and merged image) in contrast with the lack of fluorescence in the
Cuff-Vehicle mice. The self-fluorescence of the MNC-derived GFP
confirms the presence of the MNCs in the endothelial vessel of the
treated (but not the untreated) mouse and indicates that the
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tion and decreased apoptosis, even under conditions of
hypercholesterolemia.
Perivascular cuff placement has been used to induce
disturbed flow, accelerating endothelial dysfunction and
atherosclerotic lesions in medium- and large-sized arteries
in both rabbits [15] and mice [11,16,17]. Sasaki et al. [18]
adapted this model to a simultaneous ligation of the ca-
rotid artery for 7 days to induce intra-cuff thrombosis
in normocholesterolemic young mice. By a simpleFigure 5 Representative images of the results of the TUNEL
assay showing that the mononuclear cell (MNC) therapy
markedly reduces the process of apoptosis (green fluorescent
cells) in the common carotid artery under stenosis (Cuff)
compared with the Vehicle apoE-/- mouse. Scale bar: 100 μm.
treatment was able to recruit endogenous EPCs. Scale bar: 100 μm.perivascular cuff placement in our study, we were able to
generate occlusive thrombus formation in the adult
apoE-/- mice in a short time. Our achievement can be
explained by the concurrence of hypercholesterolemia,
endothelial dysfunction, age (20 weeks old) and gender, i.
e., female apoE-/- mice may be more susceptible to de-
velop endothelial dysfunction [1,8,9], and a female gender
may facilitate the progression of vessel stenosis. We ex-
pect that this thrombus formation model could be utilized
in the assessment of various known and yet-unknown
antithrombotic agents in further investigations.
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treatment of cardiovascular diseases. Stem/progenitor
cells, a subpopulation of MNCs, have unique character-
istics that make them important for therapeutic pur-
poses: they are undifferentiated and unspecialized and
can divide symmetrically and asymmetrically for long
periods of time [19-21]. As a consequence of the recent
advances in stem/progenitor cell biology, these cells have
been used to repair endogenous vascular lesions [10,22],
and our study contributes to this objective, as the MNCs
have antithrombotic properties in apoE-/- mice, even
without additional drug treatment. More specifically, it
is known that EPCs are a subset of bone marrow-
derived cells committed to the maintenance and preser-
vation of vascular turnover, remodeling and homeostasis
[23]. EPCs are immature cells that have the capacity to
be mobilized from the bone marrow into the blood-
stream in response to growth factors and cytokine re-
lease [24], may differentiate into endothelial cells and
participate in the re-endothelialization of injured vessels
and neovascularization of ischemic lesions, suggesting
that EPCs play major roles in the pathogenesis of cardio-
vascular diseases [25].
The present study provides data on the parameters of
vascular remodeling in the carotid artery cuff-induced
thrombosis model of hypercholesterolemic animals. The
main findings are that both groups, Cuff-MNC and
Cuff-Vehicle, developed carotid compensatory enlarge-
ment compared to the Sham animals, however the MNC
therapy was able to significantly reduce this enlarge-
ment. Vascular remodeling is an adaptive process that
occurs as a response to changes in hemodynamic condi-
tions [26,27], and we speculate that the outward remod-
eling was reduced by the MNC therapy as a direct
consequence of thrombus reversion or dissolution. Our
hypothesis is that the EPCs from the MNC fractions are
involved in the antithrombotic effect, as we observed the
vascular homing of the EPCs in the carotid arteries of
the apoE-/- mice treated with MNC in situ. As shown in
Figure 6, the immunofluorescence analysis showed the
presence of Sca-1 and CD117, both markers for EPCs
[28,29] and GFP-positive cells, in the carotid arteries of
the apoE-/- mice. These findings indicate the presence of
donor EPCs in the thrombotic area, suggesting that the
therapeutic effect of the MNCs was at the level of the ar-
terial wall in those animals. Our experimental model of
the nonconstrictive cuff may involve an acute turbulent
flow and the consequent exposition of the subendothe-
lium [18], which could be an effective mechanism of the
mobilization and homing of EPCs at the damaged area
[30]. Although our administration route was extravascu-
lar, other investigators demonstrated the ability of pro-
genitor cells to migrate from the adventitia into the
intima [31], corroborating our results. Moreover, othershave established that there is a protective role of the
progenitor cells that could become “exhausted” with
aging and the prolonged exposure to risk factors, such
as hypercholesterolemia [32]. Compared to autologous
transplantation, the use of healthy GFP mice, which
were used as the donors of the MNCs, provided feasible
ways of detecting the localization of the cells and their
effectiveness in cell treatment.
Disorders such as accelerated vascular damage and
impaired EPC function are related to increased oxidative
stress, which affects the mobilization, function and sur-
vival of EPCs [33]. Consequently, interventions that are
able to potentiate tissue antioxidant power, such as
pharmacological and cell therapies, have been proven to
benefit vascular integrity [34-36]. Thus, we investigated
the possible mechanisms by which EPCs could locally
mediate the attenuation of thrombosis in apoE-/- mice.
First, we tested the hypothesis that the beneficial effects
of MNC therapy could include the reduction of oxida-
tive stress and apoptosis. Our data show that the carotid
arteries of apoE-/- mice treated with MNCs exhibited a
marked decrease in the production of •O2
− and a signifi-
cant reduction in apoptosis; these results supports the
idea that the promotion of lowered oxidative stress and
the augmentation of cell viability is another important
mechanism by which MNC therapy attenuates throm-
bosis. In contrast, the cuff-induced thrombus model
exhibits greater endothelial dysfunction and ROS pro-
duction, stimulating apoptotic and inflammatory gene
expression and inducing chronic injury.
Our data suggest that cell therapy could change the
thrombotic microenvironment and provide molecular and
cellular mechanisms for the organization and recanalization
of thrombi by either autocrine or paracrine means [29].
Platelet adhesion under conditions of high shear stress,
which occurs in arteries with endothelial dysfunction, is not
only the initial step of arterial thrombosis but also an exten-
sion and perpetuation of thrombus formation [37]. Thus,
even though EPCs are involved in the synthesis and release
of soluble agonists that enhance platelet aggregation (e.g.,
5-HETE, LTB4), the antithrombotic properties of EPCs
may be mediated by an autocrine/paracrine regulation of
platelet function. Our findings show that cell therapy
reduced •O2
− production and a concomitant decrease in
endothelial TUNEL positivity, suggesting a reparative effect
of EPCs and improvements in endothelial function, re-
endothelization and neovascularization. As previously
demonstrated by Porto et al. [10], the increased num-
ber of EPCs provided by MNC treatment of apoE-/-
mice leads to decrease in ROS production and an in-
crease in NO bioavailability. This free radical is a
powerful inhibitor of platelet aggregation that works
by stimulating an increase in the intracellular levels
of cyclic guanosine monophosphate (cGMP) and
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reduced stimulation of cell proliferation could be
explained by apoptotic mechanisms. Therefore, it
seems reasonable to speculate that the reduced apop-
tosis that we observed upon MNC treatment in the
present study promotes the inhibition of phosphati-
dylserine expression [39,40] and platelet procoagulant
function. Based on other findings [41], procoagulant
platelets may also contribute to the inflammatory re-
sponse by generating proinflammatory factors and by
enhancing leukocyte adhesion. Our hypothesis is that
EPC acted to recognize the thrombi by two major
processes: proteolytic activity (which causes the shed-
ding of platelet receptors) and EPC homing (by auto-
crine modulation), which increases the speed of clot
organization and reperfusion, recanalization and con-
sequently the dissolution of the thrombus, minimizing
the time of that downstream tissues are exposed to
ischemia [42]. Other important factors that could
contribute to thrombus dissolution include arterial
blood flow and pressure, which are expected to accel-
erate the recanalization [42]. Finally, efforts to restore
the normal vascular redox balance and reduction of
apoptosis by MNC therapy may provide a therapeutic
avenue for reducing platelet-dependent thrombi and
accelerating their dissolution.
However, our study has some limitations that need to
be addressed. First, it would be interesting to demon-
strate the direct relationship between cuff placement
and hemodynamic alterations. The measurement of
hemodynamic parameters, such as blood flow velocity or
computational fluid dynamics, would help to better ex-
plain our findings. Second, a careful time course study
could clarify the progression of endothelial cell damage
in the neointima that is accompanied by thrombus with-
out plaque disruption. This could confirm whether
thrombus formation occurs independently of athero-
sclerosis because luminal thrombus rarely occurs in mice
[43]. In this study, we used a GFP-transgenic mouse as
an MNC donor because it allowed us to identify the
transplanted cells, but this animal is normolipidemic; in
contrast, autologous transplantation is usually used in
clinical practice. Further investigations should compare
the efficacy of antithrombotic MNC from apoE-/- mice
versus MNC from (GFP)-apoE+/+ donors.
In conclusion, we have shown that in situ MNC ther-
apy inhibited occlusive thrombus formation in the ca-
rotid arteries of apoE-/- mice. Our data provide evidence
that the protective mechanisms of MNC therapy include
the homing of EPCs and the reduction of oxidative stress
and apoptosis. The present data provide important evi-
dence that regenerative cell-based therapy has the po-
tential to become an effective adjuvant in the treatment
of patients with dyslipidemia and thrombosis.Competing interests
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